Correction: D Quantification of Tumor Vasculature in Lymphoma Xenografts in NOD/SCID Mice Allows to Detect Differences among Vascular-Targeted Therapies.
Main Authors: | Marco Righi, Arianna Giacomini, Loredana Cleris, Carmelo Carlo-Stella |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3618520 |
Similar Items
-
(3)D [corrected] quantification of tumor vasculature in lymphoma xenografts in NOD/SCID mice allows to detect differences among vascular-targeted therapies.
by: Marco Righi, et al.
Published: (2013-01-01) -
Correction: D Quantification of Tumor Vasculature in Lymphoma Xenografts in NOD/SCID Mice Allows to Detect Differences among Vascular-Targeted Therapies
Published: (2013-01-01) -
Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells.
by: Carmelo Carlo-Stella, et al.
Published: (2013-01-01) -
Establishment of human patient-derived endometrial cancer xenografts in NOD scid gamma mice for the study of invasion and metastasis.
by: Kenji Unno, et al.
Published: (2014-01-01) -
Spiny mice (Acomys) cells fail to engraft in NOD scid gamma.
by: Janak Gaire, et al.
Published: (2023-01-01)